Epidemiology of rheumatic diseases

Rheumatology

Volumn 39, Issue SUPPL. 2, 2000, Pages 3-12

  Sangha, O ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Disease burden; Epidemiology; Health outcomes; NSAIDs; Osteoarthritis; Rheumatoid arthritis

Indexed keywords

ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; CELECOXIB; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; DIACETYLRHEIN; HLA DR4 ANTIGEN; HYALURONIC ACID; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; SEX HORMONE;

ADOLESCENT; ADULT; AGED; ARTHROPLASTY; ARTICLE; BONE DENSITY; BONE MINERAL; CARDIOTOXICITY; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIET; DISEASE CLASSIFICATION; DISEASE CONTROL; DRUG COST; ECONOMIC ASPECT; EPIDEMIOLOGICAL DATA; FEMALE; GASTROINTESTINAL TOXICITY; HEALTH CARE COST; HEREDITY; HUMAN; INCIDENCE; MALE; MENSTRUATION; MORTALITY; OBESITY; OSTEOARTHRITIS; PATIENT CARE; PHYSIOTHERAPY; PREVALENCE; PRIORITY JOURNAL; PRODUCTIVITY; QUALITY OF LIFE; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; RISK FACTOR; SMOKING;

EID: 0034473683     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/39.suppl_2.3     Document Type: Article

References (116)

1. An historical approach to the nomenclature of rheumatoid arthritis
2. Onset of symptoms of rheumatoid arthritis in relation to age, sex, and menopausal transition
3. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
4. Revision of diagnostic criteria for rheumatoid arthritis
5. Rheumatoid arthritis
6. Epidemiology, rheumatoid arthritis, etiology, diagnosis and treatment
7. The epidemiology of rheumatoid arthritis in Rochester, Minnesota: A study of incidence, prevalence, and mortality
8. Diagnostic criteria and the incidence of rheumatoid arthritis in Sudbury, Massachusetts
9. Rheumatoid arthritis in women. Incidence rates in group health cooperative, Seattle, Washington, 1987-1989
10. The incidence of rheumatoid arthritis in the United Kingdom: Results from the Norfolk Arthritis Register
11. The pill, parity, and rheumatoid arthritis
12. The effect of pregnancy on rheumatoid arthritis
13. Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis
14. Reduction in incidence of rheumatoid arthritis associated with oral contraceptives
15. The protective effect of the oral contraceptive pill on rheumatoid arthritis: An overview of the analytic epidemiological studies using meta-analysis
16. Occurrence of rheumatoid arthritis in a nationwide series of twins
17. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis
18. Immunogenetics of rheumatoid arthritis and the Arthritis and Rheumatism Council's National Repository
19. The relationship between socioeconomic status and recently diagnosed rheumatoid arthritis
20. Formal education level as a significant marker of clinical status in rheumatoid arthritis
21. Psychological factors in chronic rheumatic diseases-a review. The case of rheumatoid arthritis, current research and some problems
22. What happens to patients with rheumatoid arthritis? The long-term outcome of treatment
23. Survival and cause of death in rheumatoid arthritis: A 25-year prospective followup
24. The mortality of rheumatoid arthritis
25. Cause of death in 81 autopsied patients with rheumatoid arthritis
26. Radiological assessment of osteoarthritis
27. Methodological problems in the epidemiological study of osteoarthritis
28. Relationship between arthroscopic evidence of cartilage damage and radiographic evidence of joint space narrowing in early osteoarthritis of the knee
29. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee
30. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand
31. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip
32. The prevalence of knee and hand osteoarthritis (OA) in the general population using different clinical criteria: The Chingford Study
33. The prevalence of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study
34. Epidemiologic considerations in the primary prevention of osteoarthritis
35. Estimates of the prevalence of rheumatic diseases in the population of Tecumseh, Michigan 1959-60
36. Joint disorders at ages 70, 75 and 79 years-cross-sectional comparison
37. Epidemiology of osteoarthritis: Zoetermeer survey. Comparison of radiological osteoarthritis in a Dutch population with that in 10 other populations
38. Knee osteoarthritis and physical functioning: Evidence from the NHANES I Epidemiologic Followup Study
39. Über die arthrosis deformans
40. The epidemiology of osteoarthritis
41. Extreme variations in racial rates of total hip arthroplasty for primary coxarthrosis: A population-based study in San Francisco
42. Upregulation of estrogen receptors in rabbit osteoarthritic cartilage
43. Estradiol induced osteoarthrosis in ovariectomized rabbits
44. Expression of estrogen receptor related protein (p29) and estradiol binding in human arthritic synovium
45. Estrogens and osteoarthritis
46. Estrogen use and radiographic osteoarthritis of the knee in women
47. Frequency of osteoarthritis in hysterectomized women
48. Is osteoarthritis in women affected by hormonal changes or smoking?
49. Estrogens, joint disease, and cartilage
50. Obesity and knee osteoarthritis. The Framingham Study
51. Incidence and progression of osteoarthritis in women with unilateral knee disease in the general population: The effect of obesity
52. Body weight, body mass index, and incident symptomatic osteoarthritis of the hand, hip, and knee
53. Obesity and osteoarthritis of the knee: Evidence from the National Health and Nutrition Examination Survey (NHANES I)
54. The relationship of obesity, fat distribution and osteoarthritis in women in the general population: The Chingford Study
55. Weight loss reduces the risk for symptomatic knee osteoarthritis in women. The Framingham Study
56. Obesity, overweight and patterns of osteoarthritis: The Ulm Osteoarthritis Study
57. Cigarette smoking and risk of osteoarthritis in women in the general population: The Chingford Study
58. An epidemiological study of severe osteoarthritis
59. Factors associated with osteoarthritis of the knee in the first national Health and Nutrition Examination Survey (HANES I). Evidence for an association with overweight, race and physical demands of work
60. Does smoking protect against osteoarthritis?
61. Osteoarthrotis of the knee in men and women in association with overweight, smoking, and hormone therapy
62. Bone mass and anthropometric measurements in adult females
63. Heavy labor and the occurrence of gonarthrosis
64. Is running associated with degenerative joint disease?
65. The risk of osteoarthritis with running and aging: 5-year longitudinal study
66. The relationship of running to osteoarthritis of the knee and hip and bone mineral density of the lumbar spine: A 9 year longitudinal study
67. Level of physical activity and the risk of radiographic and symptomatic knee osteoarthritis in the elderly: The Framingham study
68. Physical activity and self-reported, physician-diagnosed osteoarthritis: Is physical activity a risk factor?
69. Risk factors for the incidence and progression of radiographic knee osteoarthritis
70. Recreational physical activity and the risk of osteoarthritis of the hip in elderly women
71. Sports participation, sports injuries and osteoarthritis: Implications for prevention
72. The inverse relationship between osteoporosis and osteoarthritis
73. Degenerative osteoarthritis associated with osteopetrosis
74. Reproductive factors, smoking, and the risk for rheumatoid arthritis
75. Skeletal growth and articular changes in mice receiving a high fat diet
76. Skeletal growth and aging
77. Übermassige Kalziumfutterung als Ursache einer Osteoarthrose bei Jungbullen
78. Low-selenium diet, bone, and articular cartilage in rats
79. Effect of riboflavin (vitamin B2) on spontaneous gonarthrosis in the mouse
80. Effects of selenium deficiency on mouse articular cartilage
81. The effect of folate and cobalamin on osteoarthritic hands
82. Do antioxidant micronutrients protect against the development and progression of knee osteoarthritis?
83. Guidelines for the medical management of osteoarthritis. Part I. Osteoarthritis of the hip. American College of Rheumatology
84. Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology
85. North of England evidence based guideline development project: Summary of guidelines for non-steroidal anti-inflammatory drugs versus basic analgesia in treating the pain of degenerative arthritis
86. Preference for nonsteroidal antiinflammatory drugs versus acetaminophen and concomitant use of both types of drugs in patients with osteoarthritis
87. Preference for nonsteroidal antiinflammatory drugs over acetaminophen by rheumatic disease patients. A survey of 1,799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia
88. Workshop on etiopathogenesis of osteoarthritis
89. Diacerhein treatment reduces the severity of osteoarthritis in the canine cruciate-deficiency model of osteoarthritis
90. Two- to 9-year outcome after autologous chondrocyte transplantation of the knee
91. Musculoskeletal disorders: Time trends, comorbid conditions, self-assessed health status and associated activity limitations
92. Seven chronic conditions: Their impact on US adults' activity levels and use of medical services
93. Arthritis: The cumulative impact of a common chronic condition
94. Prevalence of disability and associated health conditions-United States, 1991-1992
95. Prevalence and impact of arthritis among women-United States, 1989-1991
96. Measurement of patient outcome in arthritis
97. Economics of osteoarthritis: A global perspective
98. The economic cost and social and psychological impact of musculoskeletal conditions. National Arthritis Data Work Groups
99. The cost of rheumatoid arthritis
100. Treatment of rheumatoid arthritis-does it affect society's cost for the disease?
101. Direct medical costs unique to people with arthritis
102. Indirect and nonmedical costs among people with rheumatoid arthritis and osteoarthritis compared with nonarthritic controls
103. The economics of osteoarthritis
104. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs
105. Consumption of NSAIDs and the development of congestive heart failure in elderly patients
106. Cost of NSAID adverse effects to the UK National Health Service
107. Gastrointestinal health care resource use and costs associated with nonsteroidal antiinflammatory drugs versus acetaminophen
108. Direct medical costs of disease and gastrointestinal side effects during treatment for arthritis
109. Pharmacoeconomics of NSAIDs: Beyond bleeds
110. Beyond disability: Measuring the social and personal consequences of osteoarthritis
111. Outcome assessment in rheumatology
112. The responsiveness of generic quality of life instruments in rheumatic diseases. A systematic review of randomized controlled trials